Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ishii (Tokyo, Japan), Y. Yamaguchi (Saitama, Japan), H. Hamaya (Tokyo, Japan), Y. Iwata (Tokyo, Japan), S. Ogawa (Tokyo, Japan), M. Akishita (Tokyo, Japan). Latent TGF-ß binding protein 4 is an important factor that influences anti-inflammatory and cell-protective responses in the pathogenesis of pulmonary emphysema. 1891

Member's Comments

No comment yet.

Related content which might interest you: The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 122s Year: 2003 The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease Source: International Congress 2016 – Mechanisms of disease Year: 2016 Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis Source: Eur Respir J, 57 (4) 2000652; 10.1183/13993003.00652-2020 Year: 2021 PAH and inflammation: its role in pathogenesis - is it of value to modulate it? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 The inhibitory effect of fenretinide on the expression of inflammatory cytokines, possible molecular target of the drug and its relevance to cystic fibrosis. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Altered expression of the Smad signalling pathway: implications for COPD pathogenesis Source: Eur Respir J 2006; 28: 533-541 Year: 2006 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Role of altered immune response in CF and implication for antiinflammatory therapies Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Regulation of pulmonary inflammation and its consequences by collectins and apoptotic cells Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003 TIF1? has a protective role in pulmonary fibrosis Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema Source: International Congress 2017 – Experimental PH Year: 2017